Magenta Therapeutics

-$0.12 (-1.85%) Today
+$0.10 (+1.57%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGTA and other ETFs, options, and stocks.

About MGTA

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers patient preparation, stem cell collection, cell dose, and safe immune regeneration programs.

CEO
Jason Gardner
Employees
69
Headquarters
Cambridge, Massachusetts
Founded
2015

MGTA Key Statistics

Market Cap
373.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
118.26K
High Today
$6.57
Low Today
$6.29
Open Price
$6.49
Volume
146.39K
52 Week High
$14.20
52 Week Low
$5.89

MGTA Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure